Literature DB >> 6999291

Effects of probucol on plasma cholesterol, high and low density lipoprotein cholesterol, and apolipoproteins A1 and A2 in adults with primary familial hypercholesterolemia.

M J Mellies, P S Gartside, L Glatfelter, P Vink, G Guy, G Schonfeld, C J Glueck.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6999291     DOI： 10.1016/0026-0495(80)90039-6

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  9 in total

Review 1.  A comparative review of the adverse effects of treatments for hyperlipidaemia.

Authors:  A Steiner; B Weisser; W Vetter
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

2.  Probucol suppresses enterocytic accumulation of amyloid-β induced by saturated fat and cholesterol feeding.

Authors:  Menuka M Pallebage-Gamarallage; Susan Galloway; Ryusuke Takechi; Satvinder Dhaliwal; John C L Mamo
Journal:  Lipids       Date:  2011-07-31       Impact factor: 1.880

Review 3.  An overview of lipid-lowering drugs.

Authors:  D R Illingworth
Journal:  Drugs       Date:  1988       Impact factor: 9.546

Review 4.  Treatment of hypercholesterolemia in black patients.

Authors:  J T Wright; J M McKenney; A J Wasserman
Journal:  J Natl Med Assoc       Date:  1988-09       Impact factor: 1.798

5.  Probucol and familial hypercholesterolemia.

Authors:  J Dauignon; D Bouthillier
Journal:  Can Med Assoc J       Date:  1982-05-01       Impact factor: 8.262

6.  Antiatherogenic effects of the antioxidant BO-653 in three different animal models.

Authors:  O Cynshi; Y Kawabe; T Suzuki; Y Takashima; H Kaise; M Nakamura; Y Ohba; Y Kato; K Tamura; A Hayasaka; A Higashida; H Sakaguchi; M Takeya; K Takahashi; K Inoue; N Noguchi; E Niki; T Kodama
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-18       Impact factor: 11.205

7.  Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects.

Authors:  F Heller; C Harvengt
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 8.  Lipid-lowering drugs. An overview of indications and optimum therapeutic use.

Authors:  D R Illingworth
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

Review 9.  Adverse effects of hypolipidaemic drugs.

Authors:  L C Knodel; R L Talbert
Journal:  Med Toxicol       Date:  1987 Jan-Feb
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.